Abstract
Ethnic diversity significantly influences anaesthetic pharmacology and perioperative outcomes through complex interactions between genetic, physiological, environmental and social determinants of health. There is increasing evidence suggesting that different ethnic populations demonstrate variability in anaesthetic drug metabolism, pharmacokinetics, pharmacodynamics, pain perception and recovery characteristics. Pharmacogenomic variations in cytochrome P450 enzymes contribute to clinically significant differences in opioid metabolism, sedative and analgesic response, and postoperative recovery. In addition, epigenetic influences, such as DNA methylation and histone modification, may further affect pain modulation, opioid responsiveness and susceptibility to perioperative neurocognitive effects. Ethnic disparities in perioperative care extend beyond biological variability, with minority populations demonstrating differences in access to regional anaesthesia, obstetric anaesthesia services, perioperative pain management and paediatric perioperative care. Various factors, like structural inequalities, communication barriers, implicit bias and unequal healthcare, contribute to these disparities. Advances in pharmacogenomics, artificial intelligence and precision perioperative medicine may lead to more individualized anaesthetic management in the future. However, important challenges, such as limited representation of diverse populations in research, and limited understanding of gene – environment interactions, need to be addressed. A better understanding of ethnic variability in anaesthetic pharmacology may improve anaesthetic safety, optimize perioperative drug dosing and selection, and promote equitable perioperative care across diverse patient populations.

This publication has 73 references indexed in Scilit: